Ozempic 1 MG/dose (4 MG/3 ML) 3ML
Ended Awarded
- Contract number
- SPE2DB25FAYM4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,859
Award facts
- Contract value 100% obligated
- $18,858.59 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $18,858.59 to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials. This is a firm fixed price, non-set-aside contract with an ultimate completion date of June 6, 2025, and was awarded on June 5, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated as SPE2DX, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is the prime contractor on this award. The company is a critical federal vendor specializing in supplying a broad range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. All contract awards reviewed for AmerisourceBergen demonstrate competitively awarded delivery orders with firm fixed pricing, reflecting the company's proven capability to meet federal procurement requirements. The DLA Troop Support Medical IDC encompasses a wide spectrum of pharmaceutical commodities including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains, supporting customers including the Defense Health Agency and U.S. Coast Guard.
Quick answers
Who was awarded contract SPE2DB25FAYM4?
SPE2DB25FAYM4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 5, 2025.
How much is contract SPE2DB25FAYM4 worth?
The government has obligated $18,859 on SPE2DB25FAYM4.
Is contract SPE2DB25FAYM4 an order under another contract?
Yes. SPE2DB25FAYM4 is a delivery order under SPE2DB22D3016, an indefinite delivery contract.
Was contract SPE2DB25FAYM4 competed?
The extent of competition for SPE2DB25FAYM4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award